Clinical and immunological effects of imiquimod and HPV-vaccination compared to imiquimod alone in female patients with Usual type VIN.
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2012
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary) ; Imiquimod (Primary)
- Indications Human papillomavirus infections; Vulvar intraepithelial neoplasia
- Focus Pharmacodynamics; Therapeutic Use
- 04 Aug 2011 New trial record